【目的】对中国68个主推小麦品种进行抗白粉病分析和基因推导,为白粉病流行预警和防治提供依据。【方法】2011年春季在西南、西北、长江中下游、华北、黄淮和新疆麦区等12个省(自治区)采集1 094个单孢子堆白粉病菌株,并用每个菌株分别接...【目的】对中国68个主推小麦品种进行抗白粉病分析和基因推导,为白粉病流行预警和防治提供依据。【方法】2011年春季在西南、西北、长江中下游、华北、黄淮和新疆麦区等12个省(自治区)采集1 094个单孢子堆白粉病菌株,并用每个菌株分别接种68个品种离体叶段进行抗感性测定;应用NTSYSpc2.10e软件对表型抗感性数据进行UPGAMA(unweighted pair group arithmetic mean analysis)聚类分析;用实验室长期收集保存的31个毒谱不同的菌株作为鉴别菌株对30个含已知抗白粉病基因材料和68个主推品种的离体叶段进行接种,比较68个品种和单基因材料对31个鉴别菌株的抗性谱,从而推导68个主推品种所含的抗白粉病基因。【结果】抗性测定结果表明,品种间抗谱存在明显差异。内麦8号、内麦9号和绵麦37抗谱宽,对各省菌群的抗性频率均大于99%;济麦22、扬麦11、扬麦12、扬麦13和轮选987等5个品种抗性频率在70%—90%;有54个品种的抗性频率小于40%,占供试品种总数的79.4%,表明大部分主推品种的抗性已被克服。某品种对该品种推广种植区域菌群的抗性频率低于对其它非种植区域菌群的抗性频率。聚类分析可将68个品种分成4大类,第I类包括6个品种,其中5个品种抗性频率在40%—70%;第II类包括7个品种,抗性频率均大于70%;第III类包括54个品种,抗性频率均小于40%;第IV类包括1个品种,抗性频率为46.1%;聚类显示来自于同一省的品种、抗性频率相近的品种具有相似或相近的抗性遗传背景。基因推导表明,内麦8号、内麦9号含有Pm21,偃展4110、新麦208和扬麦11均含有Pm4b;济麦22含有Pm2+ta;其余品种含有其它未知抗白粉病因子。【结论】当前中国主推小麦品种中近80%的品种对全国白粉病菌群的抗性频率不高,特别是就单个品种而言,对该品种种植区的白粉菌群抗性频率更低,存在小麦白粉病在条件适合时暴发流�展开更多
BACKGROUND: The Taq/B, Msp/ and I405V polymorphisms of cholesteryl ester transfer protein (CETP), an important regulatory factor of lipid metabolism, have been attracted much more attention by the researchers. In this...BACKGROUND: The Taq/B, Msp/ and I405V polymorphisms of cholesteryl ester transfer protein (CETP), an important regulatory factor of lipid metabolism, have been attracted much more attention by the researchers. In this study, we investigated the associations between these 3 polymorphisms of CETP gene and variations in plasma lipid and lipoprotein levels in patients with coronary heart disease (CHD). METHODS: Genomic DNA was extracted from leukocytes of 203 CHD patients and 100 control subjects using the salting out method. Genotyping of the CETP gene was performed using polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP) techniques. Statistical analysis was conducted using the SPSS 10.0 software package. RESULTS: The distribution of allele and genotype frequencies of the Taq/B, MspI, and I405V polymorphisms was similar in the CHD patient group and the control group. The B1B1 genotype of the Taq/B polymorphism was associated with significantly higher TC (P=0.039) and LDL-C (P=0.044) levels than the B2B2 genotype in CHD patients, and with significantly higher LDL-C (P=0.034) levels than the B2B2 genotype in controls. Homozygotes of the I405V polymorphism exhibited significantly higher HDL-C levels than VV homozygotes among control subjects (P=0.023). In male CHD patients with unambiguously assigned haplotypes, B2-M2-V/B2-M2-I patients demonstrated significantly higher HDL-C concentrations than B1-M2-V/B1-M2-I (P=0.023) and B1-M2-V/B1-M2-V patients (P=0.047). CONCLUSIONS: Genetic variations in the CETP gene may account for a significant proportion of the differences in plasma lipid and lipoprotein concentrations among the general population. The B1B1 genotype of the Taq/B polymorphism is probably a genetic risk factor for CHD in the study population.展开更多
The development of low-frequency ultrasound imaging technology and the improvement of ultrasound contrast agent production technology mean that they play an increasingly important role in tumor therapy. The interactio...The development of low-frequency ultrasound imaging technology and the improvement of ultrasound contrast agent production technology mean that they play an increasingly important role in tumor therapy. The interaction between ultrasound and microbubbles and their biological effects can transfer and release microbubbles carrying genes and drugs to target tissues, mediate the apoptosis of tumor cells, and block the embolization of tumor microvasculature. With the optimization of ultrasound parameters, the development of targeted microbubbles, and the emergence of various composite probes with both diagnostic and therapeutic functions, low-frequency ultrasound combined with microbubble contrast agents will bring new hope for clinical tumor treatment.展开更多
Objective: To investigate the association of Graves’ disease and Graves’ ophthalmopathy with the C/T transition polymorphism at position –318 of promoter and the A/G transition polymorphism at position 49 of exon 1...Objective: To investigate the association of Graves’ disease and Graves’ ophthalmopathy with the C/T transition polymorphism at position –318 of promoter and the A/G transition polymorphism at position 49 of exon 1 within cytotoxic T lymphocyte associated antigen-4 (CTLA-4) gene. Methods: Thirty-three patients with ophthalmopathy of Graves’ disease, fifty-six Graves’ patients without ophthalmopathy and sixty normal subjects as control were involved in the present case-control study. The polymorphisms were evaluated by polymerase chain reaction fragment length polymorphism (PCR-RFLP). Com-parisons were made of gene frequencies and allele frequencies between the groups. Results: The gene frequencies of CT and allele frequencies of T were much higher in Graves’ patients with ophthalmopathy than that in the group without ophthalmopathy (P=0.020, P=0.019). The gene frequencies of GG and allele frequencies of G in patients with Graves’ disease were significantly increased as compared with control group (P=0.008, P=0.007). The data suggest that smokers with Graves’ disease seemed to be more predisposed to ophthalmopathy than non-smokers (P=0.018). Conclusion: Our results suggest that an allele of T at position –318 of promoter is associated with genetic susceptibility to Graves’ ophthalmopathy while an allele of G at position 49 of exon 1 is associated with genetic susceptibility to Graves’ disease instead. Smoking is believed to be a major risk factor for ophthalmo-pathy.展开更多
AIM: To estimate the frequency of microdeletions in the long arm of Y-chromosome of 20 infertile males from South India. METHODS: Polymerase chain reaction (PCR) amplification using Y-specific STS of azoospermia facto...AIM: To estimate the frequency of microdeletions in the long arm of Y-chromosome of 20 infertile males from South India. METHODS: Polymerase chain reaction (PCR) amplification using Y-specific STS of azoospermia factor (AZF) regions i.e., SY 84 for AZFa, SY 127 for AZFb and SY 254 for AZFc. RESULTS: Of the 20 infertile subjects 3 (15 %), one azoospermic and two oligozoospermic, showed microdeletions in the AZF region of Y-chromosome. CONCLUSION: The frequency of deletions involving AZF region of the Y-chromosome is 15 % in azoospermic and severely oligozoospermic infertile men. PCR amplification of AZF locus is useful for the diagnosis of microdeletions in the Y-chromosome.展开更多
文摘【目的】对中国68个主推小麦品种进行抗白粉病分析和基因推导,为白粉病流行预警和防治提供依据。【方法】2011年春季在西南、西北、长江中下游、华北、黄淮和新疆麦区等12个省(自治区)采集1 094个单孢子堆白粉病菌株,并用每个菌株分别接种68个品种离体叶段进行抗感性测定;应用NTSYSpc2.10e软件对表型抗感性数据进行UPGAMA(unweighted pair group arithmetic mean analysis)聚类分析;用实验室长期收集保存的31个毒谱不同的菌株作为鉴别菌株对30个含已知抗白粉病基因材料和68个主推品种的离体叶段进行接种,比较68个品种和单基因材料对31个鉴别菌株的抗性谱,从而推导68个主推品种所含的抗白粉病基因。【结果】抗性测定结果表明,品种间抗谱存在明显差异。内麦8号、内麦9号和绵麦37抗谱宽,对各省菌群的抗性频率均大于99%;济麦22、扬麦11、扬麦12、扬麦13和轮选987等5个品种抗性频率在70%—90%;有54个品种的抗性频率小于40%,占供试品种总数的79.4%,表明大部分主推品种的抗性已被克服。某品种对该品种推广种植区域菌群的抗性频率低于对其它非种植区域菌群的抗性频率。聚类分析可将68个品种分成4大类,第I类包括6个品种,其中5个品种抗性频率在40%—70%;第II类包括7个品种,抗性频率均大于70%;第III类包括54个品种,抗性频率均小于40%;第IV类包括1个品种,抗性频率为46.1%;聚类显示来自于同一省的品种、抗性频率相近的品种具有相似或相近的抗性遗传背景。基因推导表明,内麦8号、内麦9号含有Pm21,偃展4110、新麦208和扬麦11均含有Pm4b;济麦22含有Pm2+ta;其余品种含有其它未知抗白粉病因子。【结论】当前中国主推小麦品种中近80%的品种对全国白粉病菌群的抗性频率不高,特别是就单个品种而言,对该品种种植区的白粉菌群抗性频率更低,存在小麦白粉病在条件适合时暴发流�
文摘BACKGROUND: The Taq/B, Msp/ and I405V polymorphisms of cholesteryl ester transfer protein (CETP), an important regulatory factor of lipid metabolism, have been attracted much more attention by the researchers. In this study, we investigated the associations between these 3 polymorphisms of CETP gene and variations in plasma lipid and lipoprotein levels in patients with coronary heart disease (CHD). METHODS: Genomic DNA was extracted from leukocytes of 203 CHD patients and 100 control subjects using the salting out method. Genotyping of the CETP gene was performed using polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP) techniques. Statistical analysis was conducted using the SPSS 10.0 software package. RESULTS: The distribution of allele and genotype frequencies of the Taq/B, MspI, and I405V polymorphisms was similar in the CHD patient group and the control group. The B1B1 genotype of the Taq/B polymorphism was associated with significantly higher TC (P=0.039) and LDL-C (P=0.044) levels than the B2B2 genotype in CHD patients, and with significantly higher LDL-C (P=0.034) levels than the B2B2 genotype in controls. Homozygotes of the I405V polymorphism exhibited significantly higher HDL-C levels than VV homozygotes among control subjects (P=0.023). In male CHD patients with unambiguously assigned haplotypes, B2-M2-V/B2-M2-I patients demonstrated significantly higher HDL-C concentrations than B1-M2-V/B1-M2-I (P=0.023) and B1-M2-V/B1-M2-V patients (P=0.047). CONCLUSIONS: Genetic variations in the CETP gene may account for a significant proportion of the differences in plasma lipid and lipoprotein concentrations among the general population. The B1B1 genotype of the Taq/B polymorphism is probably a genetic risk factor for CHD in the study population.
基金Project supported by the Health and Family Planning Commission of Zhejiang Province(No.2017KY676),China
文摘The development of low-frequency ultrasound imaging technology and the improvement of ultrasound contrast agent production technology mean that they play an increasingly important role in tumor therapy. The interaction between ultrasound and microbubbles and their biological effects can transfer and release microbubbles carrying genes and drugs to target tissues, mediate the apoptosis of tumor cells, and block the embolization of tumor microvasculature. With the optimization of ultrasound parameters, the development of targeted microbubbles, and the emergence of various composite probes with both diagnostic and therapeutic functions, low-frequency ultrasound combined with microbubble contrast agents will bring new hope for clinical tumor treatment.
文摘Objective: To investigate the association of Graves’ disease and Graves’ ophthalmopathy with the C/T transition polymorphism at position –318 of promoter and the A/G transition polymorphism at position 49 of exon 1 within cytotoxic T lymphocyte associated antigen-4 (CTLA-4) gene. Methods: Thirty-three patients with ophthalmopathy of Graves’ disease, fifty-six Graves’ patients without ophthalmopathy and sixty normal subjects as control were involved in the present case-control study. The polymorphisms were evaluated by polymerase chain reaction fragment length polymorphism (PCR-RFLP). Com-parisons were made of gene frequencies and allele frequencies between the groups. Results: The gene frequencies of CT and allele frequencies of T were much higher in Graves’ patients with ophthalmopathy than that in the group without ophthalmopathy (P=0.020, P=0.019). The gene frequencies of GG and allele frequencies of G in patients with Graves’ disease were significantly increased as compared with control group (P=0.008, P=0.007). The data suggest that smokers with Graves’ disease seemed to be more predisposed to ophthalmopathy than non-smokers (P=0.018). Conclusion: Our results suggest that an allele of T at position –318 of promoter is associated with genetic susceptibility to Graves’ ophthalmopathy while an allele of G at position 49 of exon 1 is associated with genetic susceptibility to Graves’ disease instead. Smoking is believed to be a major risk factor for ophthalmo-pathy.
文摘AIM: To estimate the frequency of microdeletions in the long arm of Y-chromosome of 20 infertile males from South India. METHODS: Polymerase chain reaction (PCR) amplification using Y-specific STS of azoospermia factor (AZF) regions i.e., SY 84 for AZFa, SY 127 for AZFb and SY 254 for AZFc. RESULTS: Of the 20 infertile subjects 3 (15 %), one azoospermic and two oligozoospermic, showed microdeletions in the AZF region of Y-chromosome. CONCLUSION: The frequency of deletions involving AZF region of the Y-chromosome is 15 % in azoospermic and severely oligozoospermic infertile men. PCR amplification of AZF locus is useful for the diagnosis of microdeletions in the Y-chromosome.
